维普中文期刊产品整合服务
71篇 您的检索式:作者名="Roboz GJ"
    题名 作者 年代 出处 被引量
1Phase Ⅰ / Ⅱ study of continuousnfusion troxacitabine in refractory acute myeloid leukemia 显示文摘Roboz GJ Giles FJ Ritchie EK 2007J Clin Oncol2007,25,1:1
2Phase Ⅰ/Ⅱ study of continuousinfusion troxacitabine in refractory acute myeloid leukemia显示文摘Roboz GJ Giles FJ Ritchie EK 2007J Clin Oncol2007,25,1:1
3Phase I study of epige- netic priming with decitabine prior to standard induction chemo- therapy for patients with AML 显示文摘Scandura JM Roboz GJ Moh M 2011Blood2011,118,:1
4Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leuke -mia and myelodysplastic syndrome显示文摘Roboz GJ Giles FJ List AF 2006Leukemia2006,20,6:1
5Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis 显示文摘Roboz GJ Dias S Lam G 2000Blood2000,96,4:1
6Arsenic trioxide induce dose and time dependent apoptosis of endothelium and may exert an antileukie effeet via inhibition of angiogenesis显示文摘Roboz GJ Dias S Lain G 2000Blood2000,96,4:1
7Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis 显示文摘Roboz GJ Dias S Lain G 2000Blood2000,96,4:1
8Arsenic trioxide induces dose-and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis显示文摘Roboz GJ Dias S Lam G 2000Blood2000,96,:1
9Arsenictrioxide induces dose and time dependent apoptosis of endothelium and may exert santileukemic effect via inhibition of angiogenesis显示文摘Roboz GJ Dias S Lam G 2000Blood2000,96,4:1
10A pharmacodynamic study of the flt3 inhibitor kw-2449 yields insight into the basis for clinical response显示文摘PRATZ KW CORTES J ROBOZ GJ 2009Blood2009,113,17:1
11Phase I study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML显示文摘Scandura JM Roboz GJ 2011Blood2011,118,:1
12Arseniet rioxide induces dose and time dependent apoptosis of endothelium and may exert an antileukic effect via inhibition of angiogenesis 显示文摘Roboz GJ Dias S Lam G 2000Blood2000,96,4:1
13An open-label study of CEP-701 in patients with JAK2 V617F-positive PV and ET: update of 39 enrolled patients 显示文摘Molitemo AR Hexner E Roboz GJ 2009Blood2009,114,22:1
14Arsenic trioxide enduces dose and timedependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis显示文摘Roboz GJ Dias S Lam G 2000Blood2000,96,4:1
15Arsenic trioxide induces dose-and time-dependent apoptosis of endothelium and may exert an antileukic effect via inhibition of angiogenesis显示文摘Roboz GJ Dias S Lam G 2000Blood2000,96,4:1
16Phase Ⅰ / Ⅱ study of continuous infusion troxacitabine in refractory acute myeloid leukemia显示文摘Roboz GJ Giles FJ Ritchie EK 2007J Clin Oncol2007,25,1:1
17Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML 显示文摘Scandura JM Roboz GJ Moh M 2011Blood2011,118,6:1
18Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis显示文摘Roboz GJ Dias S Lam G 1996Blood1996,70,2:1
19Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis显示文摘Roboz GJ Sergio D George L 2000Blood2000,96,4:1
20Arsenic trioxide induces dose-and time-dependent apoptosis of endothelium and may exert on antileukemia effect via inhibition of angiogenesis 显示文摘Roboz GJ Dias S Lam G 2000Blood2000,96,4:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费